How can we better manage drug‐resistant OAB/DO? ICI‐RS 2018-Reference-Cited by-同舟云学术

How can we better manage drug‐resistant OAB/DO? ICI‐RS 2018

Published:2019-12 Issue:S5 Volume:38 Page:
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Chermansky Christopher¹^ORCID,Schurch Brigitte²^ORCID,Rahnama'i Mohammad S.³⁴^ORCID,Averbeck Marcio A.⁵^ORCID,Malde Sachin⁶,Mancini Vito⁷,Valentini Francoise⁸,Sahai Arun⁶^ORCID

Affiliation:

1. Department of UrologyUniversity of Pittsburgh School of MedicinePittsburgh Pennsylvania

2. Department of Clinical Neurosciences, Neuropsychology and Neurorehabilitation ServiceVaudois University Hospital of LausanneLausanne Switzerland

3. Department of UrologyUniversity Hospital RWTH AachenAachen Germany

4. Maastricht UniversityMaastricht The Netherlands

5. Department of UrologyMoinhos de Vento HospitalPorto Alegre Brazil

6. Department of UrologyGuy's Hospital & King's College School of MedicineLondon United Kingdom

7. Urology and Renal Transplant Unit, Ospedali RiunitiUniversity of FoggiaFoggia Italy

8. Department of Physical Medicine and RehabilitationHôpital RothschildParis France

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.24055

Reference52 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society

2. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

3. OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

4. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

5. Patient factors associated with onabotulinum toxin A treatment outcome in women with detrusor overactivity

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Variable Frequency Stimulation Sacral Neuromodulation for Different Genders: A Chinese Multicentric Prospective Clinical Study;Neurourology and Urodynamics;2024-09-05

2. Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices;Advances in Therapy;2024-05-15

3. Shifts in patient preference of third‐line overactive bladder therapy after introduction of the implantable tibial nerve stimulator;Neurourology and Urodynamics;2024-02-23

4. The prevalence of probable overactive bladder and associated risk factors among medical students in Jordan: a cross-sectional study;BMC Urology;2024-01-03

5. Can we improve techniques and patients' selection for nerve stimulation suitable for lower urinary tract dysfunctions? ICI‐RS 2023;Neurourology and Urodynamics;2023-12-04